Authors:
ABE Y
ELMASRI B
KIMBALL KT
POWNALL H
REILLY CF
OSMUNDSEN K
SMITH CW
BALLANTYNE CM
Citation: Y. Abe et al., SOLUBLE CELL-ADHESION MOLECULES IN HYPERTRIGLYCERIDEMIA AND POTENTIALSIGNIFICANCE ON MONOCYTE ADHESION, Arteriosclerosis, thrombosis, and vascular biology, 18(5), 1998, pp. 723-731
Authors:
ABE Y
SMITH CW
THURMON LM
KATKIN JP
XU XD
MENDOZA LH
BALLANTYNE CM
Citation: Y. Abe et al., A2,6-LINKED SIALIC-ACID ON ENDOTHELIAL-CELLS INHIBITS VASCULAR CELL-ADHESION MOLECULE-1-DEPENDENT ADHESION UNDER FLOW CONDITIONS, Glycobiology, 8(11), 1998, pp. 103-103
Authors:
BRIAUD SA
MICHAEL L
ENTMAN ML
DANIEL S
BALLANTYNE CM
Citation: Sa. Briaud et al., MYOCARDIAL REPERFUSION INJURY AND LEUKOCYTE TRAFFICKING IN ICAM P-SELECTIN KNOCKOUT MICE/, The FASEB journal, 12(5), 1998, pp. 4492-4492
Authors:
BALLANTYNE CM
SHORT BC
BOURGE RC
EISEN HJ
FISHBEIN DP
KUBO SH
LAKE KD
BADOVANCEVIC B
TAYLOR DO
VENTURA HO
YANCY CW
YOUNG JB
Citation: Cm. Ballantyne et al., LIPID TREATMENT AND SURVIVAL AFTER HEART-TRANSPLANTATION, Journal of the American College of Cardiology, 31(2), 1998, pp. 157-158
Authors:
BALLANTYNE CM
HERD JA
DUNN JK
FERLIC LL
GOTTO AM
Citation: Cm. Ballantyne et al., LESION PROGRESSION, REGRESSION, AND STABILITY WITH FLUVASTATIN IN THELIPOPROTEIN AND CORONARY ATHEROSCLEROSIS STUDY, Journal of the American College of Cardiology, 31(2), 1998, pp. 282-282
Citation: Lm. Belalcazar et Cm. Ballantyne, DEFINING SPECIFIC GOALS OF THERAPY IN TREATING DYSLIPIDEMIA IN THE PATIENT WITH LOW HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL, Progress in cardiovascular diseases, 41(2), 1998, pp. 151-174
Authors:
FRANGOGIANNIS NG
PERRARD JL
MENDOZA LH
BURNS AR
LINDSEY ML
BALLANTYNE CM
MICHAEL LH
SMITH CW
ENTMAN ML
Citation: Ng. Frangogiannis et al., STEM-CELL FACTOR INDUCTION IS ASSOCIATED WITH MAST-CELL ACCUMULATION AFTER CANINE MYOCARDIAL-ISCHEMIA AND REPERFUSION, Circulation, 98(7), 1998, pp. 687-698
Authors:
RAO NK
XU H
CHEN ZP
NAYAK V
BALLANTYNE CM
CHAPMAN HA
SIMON DI
Citation: Nk. Rao et al., IMPAIRED MAC-1 (CD11B CD18) FUNCTION IN LEUKOCYTES FROM UROKINASE RECEPTOR-DEFICIENT MICE/, Circulation, 98(17), 1998, pp. 1232-1232
Authors:
SIMON DI
CHEN ZP
SEIFERT P
EDELMAN ER
BALLANTYNE CM
ROGERS G
Citation: Di. Simon et al., MARKEDLY REDUCED NEOINTIMAL THICKENING IN MAC-1 (CD11B CD18)-DEFICIENT MICE AFTER CAROTID-ARTERY DILATION AND ENDOTHELIAL DENUDATION/, Circulation, 98(17), 1998, pp. 1234-1234
Authors:
KUBO N
BOISVERT WA
BALLANTYNE CM
CURTISS LK
Citation: N. Kubo et al., LEUKOCYTE MAC-1 (CD11B CD18) EXPRESSION IS INCREASED IN HYPERLIPIDEMIC MICE BUT IS NOT REQUIRED FOR THE DEVELOPMENT OF ATHEROSCLEROSIS/, Circulation, 98(17), 1998, pp. 1248-1248
Authors:
SING K
BALLANTYNE CM
FERLIC L
BRUGADA R
DUNN KJ
HERD JA
POWNALL HJ
GOTTO AM
MARIAN AJ
Citation: K. Sing et al., LIPOPROTEIN-LIPASE GENE-MUTATIONS, PLASMA-LIPID LEVELS, PROGRESSION REGRESSION OF CORONARY ATHEROSCLEROSIS, RESPONSE TO THERAPY, AND FUTURECLINICAL EVENTS/, Circulation, 98(17), 1998, pp. 2798-2798
Authors:
JACOBSON TA
SCHEIN JR
WILLIAMSON A
BALLANTYNE CM
Citation: Ta. Jacobson et al., MAXIMIZING THE COST-EFFECTIVENESS OF LIPID-LOWERING THERAPY, Archives of internal medicine, 158(18), 1998, pp. 1977-1989
Citation: Cm. Ballantyne et al., INFLUENCE OF HDL-C ON CHD PROGRESSION AND RESPONSE TO TREATMENT, American journal of managed care, 3(10), 1997, pp. 1-1
Citation: Cm. Ballantyne, TREATING HYPERLIPIDEMIA TO PREVENT CORONARY HEART-DISEASE - WHAT ARE THE TREATMENT GOALS AND HOW DO WE GET THERE, American journal of managed care, 3, 1997, pp. 42-51
Citation: Cm. Ballantyne, SAFETY AND TOLERABILITY OF LIPID-LOWERING DRUGS AFTER HEART-TRANSPLANTATION - THE HEART-TRANSPLANT LIPID REGISTRY, American journal of managed care, 3, 1997, pp. 74-76
Authors:
BALLANTYNE CM
HERD JA
DUNN JK
JONES PH
FARMER JA
GOTTO AM
Citation: Cm. Ballantyne et al., EFFECTS OF LIPID-LOWERING THERAPY ON PROGRESSION OF CORONARY AND CAROTID-ARTERY DISEASE, Current opinion in lipidology, 8(6), 1997, pp. 354-361
Authors:
FRANGOGIANNIS NG
PERRARD JL
MENDOZA LH
BURNS AR
BALLANTYNE CM
MICHAEL LH
SMITH CW
ENTMAN ML
Citation: Ng. Frangogiannis et al., STEM-CELL FACTOR INDUCTION IS ASSOCIATED WITH MAST-CELL INFILTRATION FOLLOWING EXPERIMENTAL MYOCARDIAL-INFARCTION, The FASEB journal, 11(3), 1997, pp. 1648-1648
Authors:
HERD JA
WEST MS
FERLIC L
BALLANTYNE CM
GOTTO AM
Citation: Ja. Herd et al., INFLUENCE OF AGE AND SEX ON ANGIOGRAPHIC CHANGE IN THE LIPOPROTEIN AND CORONARY ATHEROSCLEROSIS STUDY (LCAS), Journal of the American College of Cardiology, 29(2), 1997, pp. 51129-51129
Authors:
BALLANTYNE CM
HERD JA
WEST MS
POWNALL HJ
FARMER JA
JONES PH
GOTTO AM
Citation: Cm. Ballantyne et al., INFLUENCE OF LOW HDL-C ON PROGRESSION OF CAD AND RESPONSE TO FLUVASTATIN THERAPY, Journal of the American College of Cardiology, 29(2), 1997, pp. 96931-96931
Authors:
BALLANTYNE CM
ELMASRI B
MORRISETT JD
TORREAMIONE G
Citation: Cm. Ballantyne et al., PATHOPHYSIOLOGY AND TREATMENT OF LIPID PERTURBATION AFTER CARDIAC TRANSPLANTATION, Current opinion in cardiology, 12(2), 1997, pp. 153-160
Authors:
WEST MS
HERD JA
BALLANTYNE CM
POWNALL HJ
SIMPSON S
GOULD L
GOTTO AM
Citation: Ms. West et al., THE LIPOPROTEIN AND CORONARY ATHEROSCLEROSIS STUDY (LCAS) - DESIGN, METHODS, AND BASE-LINE DATA OF A TRIAL OF FLUVASTATIN IN PATIENTS WITHOUT SEVERE HYPERCHOLESTEROLEMIA (VOL 17, PG 550, 1996), Controlled clinical trials, 18(1), 1997, pp. 90-90
Authors:
LU HF
SMITH CW
PERRARD J
BULLARD D
TANG LP
SHAPPELL SB
ENTMAN ML
BEAUDET AL
BALLANTYNE CM
Citation: Hf. Lu et al., LFA-1 IS SUFFICIENT IN MEDIATING NEUTROPHIL EMIGRATION IN MAC-1-DEFICIENT MICE, The Journal of clinical investigation, 99(6), 1997, pp. 1340-1350